Abhishek S.
Shipping in public. Listening in private.

Abhishek

I lead women’s Indo-Western & Premium at Max Fashion. I also wrote the AI that runs the buying floor.

Rare profile. Category operator who ships production code.

Senior Buying Leader · Max Fashion Women’s Indo-Western & Premium · 530+ India stores NIFT ’12 · Twelve years on the floor

abhishek@bengaluru ~ %
>role: senior buying lead
>dept: women’s indo-western + premium
>floor: 530+ stores india

Musical Opioid Tolerance

The same song can stop giving chills without losing its power. That is the puzzle of musical opioid tolerance: repeated pleasure seems to raise the threshold for concept frisson, yet the rare chill that still breaks through can feel stronger, not weaker.

The drug analogy is tempting but dangerous. Opioid tolerance in morphine or fentanyl involves receptor desensitization, internalization, and dose escalation. Music does not flood the brain with an external agonist; it recruits prediction, memory, attention, and endogenous reward in short pulses.

The mechanism

The strongest current model is not "music wears out the receptor." It is "music trains the gate."

Pleasurable music activates reward circuitry that overlaps with food, sex, pain relief, and drug reward. Blood and Zatorre showed in 2001 that intense music-linked pleasure recruits reward and emotion regions. Salimpoor and colleagues reported in 2011 that musical chills involve dopamine release around peak emotional moments. Mallik, Chanda, and Levitin then used naltrexone in 2017 to show that blocking opioid receptors can blunt music pleasure.

The opioid piece matters because μ-opioid receptors sit in places where pleasure becomes motivation: nucleus accumbens, orbitofrontal cortex, anterior cingulate, and related circuits. A chill is not just sound. It is the body marking a prediction error as valuable.

What the evidence says

The empirical pattern is split. Repetition usually reduces the chance of chills because the brain learns the passage. The drop before a chorus, the delayed cadence, the singer's break on one syllable: after five or fifty hearings, the brain sees it coming.

But intensity can survive repetition when the passage carries personal memory, social context, or a precisely timed violation of expectation. That is why a concert encore can still hit harder than the same track on a phone. The stimulus is familiar; the situation is not.

Pattern Drug opioid tolerance Musical repetition
Repeated exposure Daily receptor agonism Repeated predictive cue
Threshold Usually rises Often rises
Peak response Often blunted Can stay high or rise
Main driver Pharmacology Prediction plus affect

The cleanest test would be a longitudinal PET study using [11C]carfentanil: scan listeners before and after 4 to 8 weeks of daily chill-targeted listening, then compare μ-opioid receptor binding in nucleus accumbens and orbitofrontal cortex. As of 2026-06-28, I do not know of a published study that has done this exact experiment.

The 2025 empirical baseline. Schoeller and colleagues published the first controlled study of repeated exposure to chill-evoking stimuli in PLOS One (April 2025, PMC11964268). 58 participants were exposed to six pre-validated chill-evoking audiovisual stimuli (sourced from YouTube and Reddit, empirically validated across 3,500+ listeners) in counterbalanced order across multiple sessions. The finding is a clean paradox:

This mirrors a known pattern in pharmacology: opioid tolerance can reduce the probability of peak hedonic response while the response itself, when triggered, becomes more salient. The brain has not lost the capacity for the response; it has raised the threshold.

The Schoeller study used different compositions across sessions (not the same piece repeated), which means the decreased likelihood is not composition-specific. It is category-level: after six sessions of chill stimuli, the brain is primed to expect peaks, which paradoxically suppresses them. This is a form of aesthetic tolerance that operates at the genre level, not the composition level — an important distinction for rotation protocols.

Composition cross-tolerance: the open question

Opioid pharmacology distinguishes tolerance (reduced response to the same molecule) from cross-tolerance (reduced response to a related molecule acting at the same receptor). Cross-tolerance is typically incomplete — which is why rotation works clinically.

The analogous question for music: if you habituate to Barber's Adagio for Strings, does that reduce your chill response to other Barber works? To other Romantic-era music? To all high-yield frisson passages globally? The Schoeller (2025) study used different compositions per session, showing category-level tolerance. But the specificity of that tolerance — composer, genre, emotional valence, tempo contour — has not been mapped.

Tolerance level Drug analogy Music question
Composition-specific Same molecule Barber Adagio → only Barber?
Composer-specific Drug class Barber → other Barber but not Beethoven?
Genre-specific Opioid class Classical → all classical?
Peak-emotion-specific MOR agonism generally All frisson passages equally?

If cross-tolerance is incomplete at the composition level (habituating to Barber does not reduce response to Beethoven's 9th), then a rotation protocol needs to change composition, not just timing. If cross-tolerance operates at genre level (all classical habituates together), the rotation must cross genres. The therapeutic implication is concrete: any frisson-based analgesia protocol needs to know the scope of cross-tolerance before designing its rotation schedule.

This gap was explicitly identified in the existing literature by 2026 but no study has run the controlled cross-tolerance mapping.

What's contested

The contested question is whether "tolerance" is even the right word. If repeated music lowers surprise but preserves pleasure through memory, the mechanism is closer to habituation than receptor-level opioid tolerance. The Schoeller paradox — decreased likelihood but increased intensity — is hard to explain with pure receptor desensitization; it fits better with a prediction-gating model where the brain raises the threshold for registering a peak while the underlying hedonic capacity is preserved.

A second uncertainty is measurement. Chills, skin conductance, pupil dilation, PET binding, self-report, and pain tolerance are related signals, not the same signal. A person can feel deep pleasure without visible goosebumps, which makes concept music analgesia harder to dose like a drug.

A third uncertainty: the Schoeller (2025) result used a 6-session protocol with validated stimuli. Whether the same likelihood-decrease + intensity-increase pattern holds over months, or whether intensity eventually also declines, is not established.

Why this has to do with other realms

The bridge to concept raga theory is sharper than the clinical literature admits. A time-bound raga system rotates melodic material across the day; whether or not the old theory was neurochemical, it behaves like an anti-habituation protocol.

The bridge to biology is pain. If concept frisson pharmacopeia ever becomes more than a metaphor, the protocol cannot be "play the strongest song forever." It has to look more like crop rotation: novelty, rest, timing, and personal response curves.

Key sources

Further reading

See Also

Abhishek's take

The useful idea here is not that songs are tiny opioids. The useful idea is that pleasure has an inventory problem: repeat the same trigger too often and the brain starts pricing it differently. I care about this because any serious music-as-medicine protocol has to answer the operator's question first: what is the rotation schedule?

Tags: #frisson #mu-opioid-receptor #habituation #tolerance #analgesia #pharmacology #music-neuroscience